Knee Surgery

CORRECT: Omeros Shares Drop After Knee-Surgery Treatment Fails To Meet Goals - Wall Street Journal
CORRECT: Omeros Shares Drop After Knee-Surgery Treatment Fails To Meet GoalsWall Street Journal(OMER) shares slumped Thursday after a Phase-3 study evaluating a Knee-reconstruction Surgery treatment failed to meet its pre-specified endpoints. Shares plummeted 38% to $5 after-hours Thursday. The stock had previously risen 23% through Thursday's ...Omeros Fails in Pivotal Trials With Drug for Knee Surgery, Stock CrashesXconomyOmeros says Knee drug does not meet study goalBusinessWeekOmeros says Knee drug disappoints in late-stage studyReutersBizjournals.com (blog)�-StreetInsider.com (subscription)�-FierceBiotechall 42 news articles��

Blog Content